OKUR OnKure Therapeutics Inc.
Price (delayed)
$3.13
Market cap
$42.05M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$15.28
Enterprise value
-$67.62M
Highlights
OKUR's EPS has surged by 88% year-on-year and by 86% since the previous quarter
The equity is up by 40% since the previous quarter
The quick ratio has soared by 157% YoY but it has plunged by 55% from the previous quarter
OKUR's debt has surged by 63% since the previous quarter and by 61% year-on-year
OnKure Therapeutics's net income has decreased by 49% YoY
Key stats
What are the main financial stats of OKUR
Market
Valuations
Earnings
Shares outstanding
13.44M
Market cap
$42.05M
Enterprise value
-$67.62M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.4
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$54.39M
Net income
-$52.67M
EBIT
-$52.37M
EBITDA
-$51.71M
Free cash flow
-$51.17M
Per share
Balance sheet
Liquidity
EPS
-$15.28
EPS diluted
-$15.28
Free cash flow per share
-$14.84
Book value per share
$7.78
Revenue per share
$0
TBVPS
$33.33
Total assets
$114.91M
Total liabilities
$11.08M
Debt
$1.09M
Equity
$103.83M
Working capital
$102.47M
Debt to equity
0.01
Current ratio
10.73
Quick ratio
10.52
Net debt/EBITDA
2.12
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-59.2%
Return on equity
-62.7%
Return on invested capital
-184.3%
Return on capital employed
-50.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OKUR stock price
How has the OnKure Therapeutics stock price performed over time
Intraday
-19.54%
1 week
-29.82%
1 month
-39.69%
1 year
N/A
YTD
-63.6%
QTD
-27.21%
Financial performance
How have OnKure Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$54.39M
Net income
-$52.67M
Gross margin
N/A
Net margin
N/A
OnKure Therapeutics's net income has decreased by 49% YoY
OnKure Therapeutics's operating income has decreased by 47% YoY
Growth
What is OnKure Therapeutics's growth rate over time
Valuation
What is OnKure Therapeutics stock price valuation
P/E
N/A
P/B
0.4
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
OKUR's EPS has surged by 88% year-on-year and by 86% since the previous quarter
The P/B is 50% less than the last 4 quarters average of 0.8
The equity is up by 40% since the previous quarter
Efficiency
How efficient is OnKure Therapeutics business performance
OKUR's ROA has dropped by 73% year-on-year
OKUR's ROE is down by 3.3% year-on-year
Dividends
What is OKUR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OKUR.
Financial health
How did OnKure Therapeutics financials performed over time
The quick ratio has soared by 157% YoY but it has plunged by 55% from the previous quarter
OnKure Therapeutics's current ratio has soared by 131% YoY but it has plunged by 55% from the previous quarter
OKUR's debt is 99% smaller than its equity
OnKure Therapeutics's debt to equity has soared by 200% YoY
OKUR's debt has surged by 63% since the previous quarter and by 61% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.